Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 1,201–1,400 of 1,461
Sandø, N., Kofoed, K. F., Zachariae, C. O. C., & Fouchard, J. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1721 · Cited by 27
Ahmed, K. A., Fox, S. J., Frigas, E., & Park, M. A. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000333553 · Cited by 26
Adenocarcinoma arising in sigmoid colon neovagina 53 years after construction.
Yamada, K., Shida, D., Kato, T., Yoshida, H., Yoshinaga, S., & Kanemitsu, Y. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1372-z · Cited by 26
Falk, L. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0924 · Cited by 26
What Do We Know About Males and Emergency Contraception? A Synthesis of the Literature
Marcell, A. V., Waks, A. B., Rutkow, L., McKenna, R., Rompalo, A. M., & Hogan, M. T. (2012) · Perspectives on Sexual and Reproductive Health · doi:10.1363/4418412 · Cited by 26
Modified Oral Metronidazole Desensitization Protocol
Gendelman, S. R., Pien, L. C., Gutta, R. C., & Abouhassan, S. R. (2014) · Allergy & Rhinology · doi:10.2500/ar.2014.5.0080 · Cited by 26
Screening for HIV Infection in Pregnant Women
Selph, S., Bougatsos, C., Dana, T., et al. (2019) · JAMA · doi:10.1001/jama.2019.2593 · Cited by 26
Mehta, S. D., Moses, S., Agot, K., Maclean, I., Odoyo-June, E., Li, H., & Bailey, R. C. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit371 · Cited by 26
Establishing an HIV screening program led by staff nurses in a county jail.
Spaulding, A. C., Kim, M. J., Corpening, K. T., Carpenter, T., Watlington, P., & Bowden, C. J. (2015) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000183 · Cited by 26
Hospitalization for Pelvic Inflammatory Disease: A Cost-Effectiveness Analysis
Smith, K. J., Ness, R. B., & Roberts, M. S. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000225321.61049.13 · Cited by 26
KISSINGER, P. J., White, S., Manhart, L. E., Schwebke, J. R., Taylor, S. N., Mena, L. A., Khosropour, C. M., Wilcox, L., Schmidt, N., & Martin, D. H. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000489 · Cited by 26
Sosman, J. M., MacGowan, R. J., Margolis, A. D., Eldridge, G. D., Flanigan, T., Vardaman, J., Fitzgerald, C., Kacanek, D., Binson, D., Seal, D. W., et al. (2005) · International Journal of STD & AIDS · doi:10.1258/0956462053057594 · Cited by 26
Medina, M. M., Crowley, C., Montgomery, M. C., Tributino, A., Almonte, A., Sowemimo-Coker, G., Nunn, A., & Chan, P. A. (2019) · AIDS and Behavior · doi:10.1007/s10461-018-2286-z · Cited by 26
Self-citationChlamydia partner services for females in California family planning clinics.
Yu, Y.-Y., Frasure-Williams, J. A., Dunne, E. F., Bolan, G., Markowitz, L., & Bauer, H. M. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182240366 · Cited by 26
Self-citationMetronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study
Chavoustie, S. E., Jacobs, M., Reisman, H., Waldbaum, A. S., Levy, S. F., Hillier, S. L., & Nyirjesy, P. (2014) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000062 · Cited by 26
Implementation and effectiveness of an expedited partner therapy program in an urban clinic.
Mickiewicz, T., Al-Tayyib, A., Thrun, M., & Rietmeijer, C. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182756f20 · Cited by 26
Stephens, S. C., Bernstein, K. T., Katz, M. H., Philip, S. S., & Klausner, J. D. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181d8920f · Cited by 26
Javanbakht, M., Stirland, A., Stahlman, S., Smith, L. V., Chien, M., Torres, R., & Guerry, S. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000026 · Cited by 26
Sarıer, M., Sepin, N., Duman, İ., et al. (2018) · Andrologia · doi:10.1111/and.13143 · Cited by 26
Failure of Nitazoxanide to Cure Trichomoniasis in Three Women
Dan, M., & Sobel, J. D. (2007) · Sexually Transmitted Diseases · doi:10.1097/nmd.0b013e31802f5d9a · Cited by 26
Hepatitis A vaccine immune response 22 years after vaccination.
Mosites, E., Gounder, P., Snowball, M., Morris, J., Spradling, P., Nelson, N., Bulkow, L., Bruce, M., & McMahon, B. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25197 · Cited by 25
Hiransuthikul, A., Janamnuaysook, R., Sungsing, T., Jantarapakde, J., Trachunthong, D., Mills, S., Vannakit, R., Phanuphak, P., & Phanuphak, N. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053835 · Cited by 25
Early Repeat Chlamydia trachomatis and Neisseria gonorrhoeae Infections Among Heterosexual Men
KISSINGER, P. J., Reilly, K. H., Taylor, S. N., Leichliter, J. S., Rosenthal, S. L., & Martin, D. H. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a4d147 · Cited by 25
Influence of Human Immunodeficiency Virus Infection on Pelvic Inflammatory Disease
Irwin, K. L., Moorman, A. C., O’Sullivan, M. J., et al. (2000) · Obstetrics and Gynecology · doi:10.1097/00006250-200004000-00010 · Cited by 25
Simons, R., Candfield, S., French, P., & White, J. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000772 · Cited by 25
Patel, P., Bush, T., Mayer, K., Milam, J., Richardson, J., Hammer, J., Henry, K., Overton, T., Conley, L., Marks, G., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824b3110 · Cited by 25
Acceptability of digital anal cancer screening examinations in HIV ‐positive homosexual men
Read, T., Vodstrcil, L. A., Grulich, A., et al. (2013) · HIV Medicine · doi:10.1111/hiv.12035 · Cited by 25
Treatment of Trichomoniasis in Pregnancy and Preterm Birth: An Observational Study
Mann, J. R., McDermott, S. W., Zhou, L., Barnes, T. L., & Hardin, J. W. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.0964 · Cited by 25
Prevalence of Trichomonas vaginalis Infection Among US Males, 2013–2016
Daugherty, M., Glynn, K., & Byler, T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy499 · Cited by 25
Single Dose Treatment of Trichomoniasis
Gabriel, G. R. B., Robertson, E., & Thin, R. N. (1982) · Journal of International Medical Research · doi:10.1177/030006058201000212 · Cited by 25
Vandepitte, J., Bukenya, J. N., Hughes, P. J., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824b1cf3 · Cited by 25
Olson, K. M., Boohaker, L. J., Schwebke, J. R., Aslibekyan, S., & Muzny, C. A. (2018) · Sexual Health · doi:10.1071/sh17087 · Cited by 25
Self-citationHidalgo-Tenorio, C., Rivero-Rodriguez, M., Gil-Anguita, C., Esquivias, J., López-Castro, R., Ramírez-Taboada, J., de Hierro, M. L., López-Ruiz, M. A., Martínez, R. J., & Llaño, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123590 · Cited by 25
Owusu-Edusei, K., Gift, T. L., Chesson, H. W., & Kent, C. K. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws240 · Cited by 25
Dai, S., Chi, P., Lin, Y., Zheng, X., Liu, W., Zhang, J., Zeng, Q., Wu, X., Liu, W., & Wang, J. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000066 · Cited by 25
Leichliter, J. S., Dittus, P. J., Copen, C. E., & Aral, S. O. (2020) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054045 · Cited by 25
Matsuki, S., Kusatake, K., Hein, K. Z., Anraku, K., & Morita, E. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462414542476 · Cited by 25
Deguchi, T., Ito, S., Hatazaki, K., Horie, K., Yasuda, M., Nakane, K., Mizutani, K., Tsuchiya, T., Yokoi, S., Hanaoka, N., et al. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.05.009 · Cited by 25
Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis
Mallah, N., Tohidinik, H. R., Etminan, M., Figueiras, A., & Takkouche, B. (2019) · Drug Safety · doi:10.1007/s40264-019-00884-5 · Cited by 25
Gallion, H. R., Dupree, L. J., Scott, T. A., & Arnold, D. H. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.12.006 · Cited by 25
Sexually transmitted infections and hepatitis in men with a history of incarceration.
Sosman, J., MacGowan, R., Margolis, A., Gaydos, C. A., Eldridge, G., Moss, S., Flanigan, T., Iqbal, K., & Belcher, L. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31820bc86c · Cited by 24
Ito, S., Hatazaki, K., Shimuta, K., Kondo, H., Mizutani, K., Yasuda, M., Nakane, K., Tsuchiya, T., Yokoi, S., Nakano, M., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000573 · Cited by 24
Binnicker, M. J., Espy, M. J., Duresko, B. J., Irish, C. L., & Mandrekar, J. N. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.02.006 · Cited by 24
(2013) · PubMed · Cited by 24
Split-dose Metronidazole or Single-dose Tinidazole for the Treatment of Vaginal Trichomoniasis
O‐Prasertsawat, P., & Jetsawangsri, T. (1992) · Sexually Transmitted Diseases · doi:10.1097/00007435-199209000-00011 · Cited by 24
Taylor, L. E., DeLong, A. K., Maynard, M. A., Chapman, S., Gholam, P., Blackard, J. T., Rich, J., & Mayer, K. H. (2011) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0106 · Cited by 24
Mycoplasma genitaliumserum antibodies in infertile couples and fertile women: Table 1
Idahl, A., Jurstrand, M., Olofsson, J. I., & Fredlund, H. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052011 · Cited by 24
Pathela, P., Jamison, K., Kornblum, J. S., Quinlan, T. M., Halse, T. A., & Schillinger, J. A. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000921 · Cited by 23
Libois, A., Hallin, M., Crucitti, T., Delforge, M., & Wit, S. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196217 · Cited by 23
Jannic, A., Mammeri, H., Larcher, L., Descamps, V., Tosini, W., Phung, B., Yazdanpanah, Y., & Bouscarat, F. (2018) · Emerging infectious diseases · doi:10.3201/eid2501.171102 · Cited by 23
Bodsworth, N., Crooks, R. J., Borelli, S., Vejlsgaard, G. L., Paavonen, J. A., Worm, A. M., Uexkull, N., Esmann, J., Strand, A., Ingamells, A. J., et al. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63673-5 · Cited by 23
Gherardi, G., Bonaventura, G. D., Pompilio, A., et al. (2015) · IDCases · doi:10.1016/j.idcr.2015.03.001 · Cited by 23
McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J., & Jones, H. E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000975 · Cited by 23
Cheng, S.-H., Wang, C.-C., Chang, S.-L., Chu, F.-Y., & Hsueh, Y.-M. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0804-9 · Cited by 23
Cost-Effectiveness of Alternative Outpatient Pelvic Inflammatory Disease Treatment Strategies
Smith, K. J., Ness, R. B., Wiesenfeld, H. C., et al. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181161d47 · Cited by 23
Human Papillomavirus Vaccine Knowledge and Intention Among Adult Inmates in Kansas, 2016–2017
Allison, M. J., Musser, B., Satterwhite, C. L., Ault, K. A., Kelly, P. J., & Ramaswamy, M. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304499 · Cited by 23
Darville, T. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000028 · Cited by 23
Urethritis Caused by NovelNeisseria meningitidisSerogroup W in Man Who Has Sex with Men, Japan
Hayakawa, K., Itoda, I., Shimuta, K., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2009.140349 · Cited by 23
Corynebacterium propinquum Associated With Acute, Nongonococcal Urethritis
Abdolrasouli, A., & Roushan, A. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000027 · Cited by 23
Condylomata gigantea in a male transsexual
Yang, C., Liu, S., Xu, K., Xiang, Q., Yang, S., & Zhang, X. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008213 · Cited by 23
Ong, J. J., Grulich, A. E., Walker, S. M., et al. (2015) · Journal of Medical Screening · doi:10.1177/0969141315604658 · Cited by 23
Single-Dose Treatment of Trichomonal Vaginitis: A Comparison of Tinidazole and Metronidazole
Anjaneyulu, R., Gupte, S. A., & Desai, D. B. (1973) · Journal of International Medical Research · doi:10.1177/030006057300100210 · Cited by 23
Hammerschlag, M., Cummings, C., Roblin, P. M., Williams, T. H., & Delke, I. (1989) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(89)90320-2 · Cited by 23
Shigella sonnei outbreak among men who have sex with men in Tokyo.
Okame, M., Adachi, E., Sato, H., Shimizu, S., Kikuchi, T., Miyazaki, N., Koga, M., Nakamura, H., Suzuki, M., Oyaizu, N., et al. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.277 · Cited by 23
ACOG Committee Opinion No. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing
Pollock, L. C., Cohan, D., Pecci, C. C., et al. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003048 · Cited by 22
Nijhawan, A. E., DeLong, A. K., Celentano, D. D., Klein, R. S., Sobel, J. D., Jamieson, D. J., & Cu-Uvin, S. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822ea147 · Cited by 22
Imiquimod reactivation of lichen planus.
Domingues, E., Chaney, K. C., Scharf, M. J., & Wiss, K. (2012) · PubMed · Cited by 22
Teo, J. W. P., Chiang, D., Jureen, R., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.07.018 · Cited by 22
Pharmacy-level barriers to implementing expedited partner therapy in Baltimore, Maryland
Qin, J. Z., Diniz, C. P., & Coleman, J. S. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.036 · Cited by 22
Topical microbicides and HIV prevention in the female genital tract.
Cottrell, M. L., & Kashuba, A. D. M. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.292 · Cited by 22
Tuite, A. R., Shaw, S., Reimer, J. N., Ross, C. P., Fisman, D. N., & Mishra, S. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053201 · Cited by 22
Berry, L., & Stanley, B. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000428 · Cited by 22
Donovanosis causing lymphadenitis, mastoiditis, and meningitis in a child
Ahmed, N., Pillay, A., Lawler, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60992-8 · Cited by 22
Collart, P., Poitevin, M., Milovanovic, A., Herlin, A., & Durel, J. (1980) · Sexually Transmitted Infections · doi:10.1136/sti.56.6.355 · Cited by 22
Koper, N. E., van der Sande, M. A. B., Götz, H. M., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.34.20561 · Cited by 22
Claydon, E., Murphy, S., Osborne, E. M., Kitchen, V, Smith, J. R., & Harris, J. R. W. (1991) · International Journal of STD & AIDS · doi:10.1177/095646249100200310 · Cited by 22
Kachur, R. E., Hall, W. J., Coor, A., Kinsey, J., Collins, D. E., & Strona, F. V. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000864 · Cited by 22
Gopalappa, C., Huang, Y.-L. A., Gift, T. L., Owusu‐Edusei, K., Taylor, M. M., & Gales, V. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000023 · Cited by 22
Cole, J., Hotton, A., Zawitz, C., & Kessler, H. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000106 · Cited by 21
(2008) · PubMed · Cited by 21
Raifman, J. R., Gebo, K. A., Mathews, W. C., Korthuis, P. T., Ghanem, K. G., Aberg, J. A., Moore, R. D., Nijhawan, A. E., Monroe, A. K., Berry, S. A., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001514 · Cited by 21
Page, E. E., & Nelson, M. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-2-189 · Cited by 21
Chen, M. J., Kim, C. R., Whitehouse, K., Berry‐Bibee, E., & Gaffield, M. E. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12064 · Cited by 21
Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy, K. M., Goldberg, D. J., Hutchinson, S., Cameron, S. O., Wilson, K., & MacDonald, L. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20146 · Cited by 21
Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman.
Elfering, L., van der Sluis, W. B., Mermans, J. F., & Buncamper, M. E. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416685658 · Cited by 20
Hotton, A. L., Gratzer, B., & Mehta, S. D. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31826e870d · Cited by 20
The role of behavioral counseling in sexually transmitted disease prevention program settings.
Brookmeyer, K. A., Hogben, M., & Kinsey, J. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000327 · Cited by 20
Shigella flexneri serotype 1 infections in men who have sex with men in Vancouver, Canada
Wilmer, A., Romney, M., Gustafson, R., Sandhu, J., Chu, T., Ng, C., Hoang, L., Champagne, S., & Hull, M. (2015) · HIV Medicine · doi:10.1111/hiv.12191 · Cited by 20
Use of Treponemal Screening Assay Strength of Signal to Avoid Unnecessary Confirmatory Testing
Berry, G. J., & Loeffelholz, M. J. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000524 · Cited by 20
Repeat Screening for Sexually Transmitted Infection in Adolescent Obstetric Patients
Aggarwal, A., Spitzer, R. F., Caccia, N. C., et al. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34683-7 · Cited by 20
Inadvertent use of Bicillin C-R to treat syphilis infection--Los Angeles, California, 1999-2004.
Bolan, R., Amezola, P., Kerndt, P. R., et al. (2005) · MMWR Morbidity and Mortality Weekly Report · Cited by 20
HBV infection in relation to consistent condom use: a population-based study in Peru.
Bernabe-Ortiz, A., Carcamo, C. P., Scott, J. D., Hughes, J. P., Garcia, P. J., & Holmes, K. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024721 · Cited by 20
Marotta, M., Toni, F., Dallolio, L., Toni, G., & Leoni, E. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.12.004 · Cited by 20
Salow, K. R., Cohen, A. C., Bristow, C., McGrath, M. R., & Klausner, J. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189515 · Cited by 19
HSV type specific serology in sexual health clinics: use, benefits, and who gets tested
Song, B. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.006783 · Cited by 19
Multidrug-Resistant Campylobacter coli in Men Who Have Sex with Men, Quebec, Canada, 2015
Gaudreau, C., Pilon, P. A., Sylvestre, J.-L., Boucher, F., & Bekal, S. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.151695 · Cited by 19
Mondeja, B., Couri, J., Preval, N. M. R., Blanco, O., Fernández, C., & Jensen, J. S. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3523-9 · Cited by 19
Comparing HIV case detection in prison during opt-in vs. opt-out testing policies.
Rosen, D. L., Wohl, D. A., Golin, C. E., Rigdon, J., May, J., White, B. L., Leone, P. A., Hudgens, M. G., & Bowling, J. M. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000889 · Cited by 19
Provider adherence to syphilis testing recommendations for women delivering a stillbirth.
Patel, C. G., Huppert, J. S., & Tao, G. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000656 · Cited by 19
Schick, V., Pol, B. J. V. D., Dodge, B., Baldwin, A., & Fortenberry, J. D. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051842 · Cited by 19
Audisio, T., Pigini, T., de Riutort, S. V., et al. (2001) · Journal of Lower Genital Tract Disease · doi:10.1046/j.1526-0976.2001.54007.x · Cited by 19
Ngo, T. D., Laeyendecker, O. B., La, H. B., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00437-06 · Cited by 19
Donovanosis and squamous cell carcinoma: The relationship conundrum!
Arora, A. K., Kumaran, M. S., Narang, T. K., et al. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416665996 · Cited by 19
Frentz, G., Nielsen, P. B., Espersen, F., Czartoryski, A., & Aastrup, H. (1984) · European Journal of Clinical Microbiology · doi:10.1007/bf02014334 · Cited by 19
Kiweewa, F. M., Brown, E., Mishra, A., Nair, G., Palanee‐Phillips, T., Mgodi, N., Nakabiito, C., Chakhtoura, N., Hillier, S. L., Baeten, J. M., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25257 · Cited by 19
Scott, N., McBryde, E. S., Kirwan, A., & Stoove, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144869 · Cited by 19
Manhart, L. E., Khosropour, C. M., Gillespie, C. W., Lowens, M. S., Golden, M. R., & Totten, P. A. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051184.0091 · Cited by 19
Holt, B. Y., Dellplain, L., Creinin, M. D., Peine, K. J., Romano, J., & Hemmerling, A. (2018) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1508650 · Cited by 19
Samaraweera, G., Garcia, K., Druce, J. D., Williams, H., Bradshaw, C. S., Fairley, C. K., Chow, E. P. F., Denham, I., Read, T. R. H., & Chen, M. Y. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052243 · Cited by 19
Oliphant, J., & Azariah, S. (2013) · Sexual Health · doi:10.1071/sh12168 · Cited by 18
Tandon, S., Singh, J., Sinha, S., et al. (2017) · Dermatologic Therapy · doi:10.1111/dth.12479 · Cited by 18
Topical cidofovir for treatment of resistant viral infections.
McElhiney, L. F. (2006) · PubMed · Cited by 18
Jenness, S. M., Weiss, K. M., Prasad, P., Zlotorzynska, M., & Sanchez, T. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000896 · Cited by 18
Pubic hair removal and Phthirus pubis infestation
Veraldi, S., Schianchi, R., Ramoni, S., & Nazzaro, G. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462417740292 · Cited by 18
Muzny, C. A., Rivers, C. A., Mena, L. A., & Schwebke, J. R. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824f1c49 · Cited by 18
Self-citationShaikh, R. A., Simonsen, K. A., O’Keefe, A., Earley, M., Foxall, M., Islam, K. M., Person, A., Boyle, C., Sandkovsky, U., & Margalit, R. (2015) · Journal of Correctional Health Care · doi:10.1177/1078345815600447 · Cited by 18
Ignacio, R. B., Perti, T., Magaret, A., Rajagopal, S., Stevens, C. E., Huang, M.-L. W., Selke, S., Johnston, C., Marrazzo, J. M., & Wald, A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv317 · Cited by 18
Self-citationMagdaleno-Tapial, J., Valenzuela-Oñate, C., Giacaman-von der Weth, M. M., Ferrer-Guillén, B., Martínez-Domenech, Á., García-Legaz Martínez, M., Ortiz-Salvador, J. M., Subiabre-Ferrer, D., & Hernández-Bel, P. (2019) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2018.09.003 · Cited by 18
Patient delivered partner therapy for chlamydial infection—what would be missed?
McNulty, A., Teh, M. F., & Freedman, E. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181761993 · Cited by 18
Chambers, L. C., Jensen, J. S., Morgan, J. L., Lowens, M. S., Romano, S. S., Totten, P. A., Soge, O. O., Hughes, J. P., Golden, M. R., & Manhart, L. E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001035 · Cited by 18
A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy
Masese, L. N., Graham, S. M., Gitau, R., Peshu, N., Jaoko, W. G., Ndinya‐Achola, J. O., Mandaliya, K. N., Richardson, B. A., Overbaugh, J. M., & McClelland, R. S. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-307 · Cited by 18
Identification of False-Positive Syphilis Antibody Results Using a Semiquantitative Algorithm
Yen‐Lieberman, B., Daniel, J., Means, C., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05066-11 · Cited by 18
Moro, P. L., Arana, J., Marquez, P. L., Ng, C., Barash, F., Hibbs, B. F., & Cano, M. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.088 · Cited by 17
Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies
Ahmad, H. M., Abdel-Azim, E. S., & Abdel-Aziz, R. T. (2016) · Dermatologic Therapy · doi:10.1111/dth.12310 · Cited by 17
Group B streptococcal vaginitis in postpubertal adolescent girls
Clark, L. R., & Atendido, M. (2005) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.03.009 · Cited by 17
Tinidazole in the Treatment of Trichomoniasis, Giardiasis and Amoebiasis
Apte, V. V., & Packard, R. S. (1978) · Drugs · doi:10.2165/00003495-197800151-00009 · Cited by 17
Fierer, D. S., Mullen, M. P., Dieterich, D. T., Isabel Fiel, M., & Branch, A. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis538 · Cited by 17
Geisler, W. M., Koltun, W. D., Abdelsayed, N., Burigo, J., Mena, L. A., Taylor, S. N., Batteiger, B. E., Thurman, A. R., Hook, E. W., Vaughn, T. A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis291 · Cited by 17
Iribarren Díaz, M., Ocampo Hermida, A., González-Carreró Fojón, J., Longueira Suárez, R., Rivera Gallego, A., Casal Núñez, E., Ocampo Álvarez, A., & Cachay, E. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4274/2016 · Cited by 17
Piñeiro, L., Idígoras, P., de la Caba, I., et al. (2019) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2019.03.005 · Cited by 17
Ong, J. J., Morton, A. N., Henzell, H., Berzins, K., Druce, J. D., Fairley, C. K., Bradshaw, C. S., Read, T. R. H., Hocking, J. S., & Chen, M. Y. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000547 · Cited by 17
de Voux, A., Bernstein, K. T., Bradley, H., Kirkcaldy, R. D., Tie, Y., Shouse, R. L., & Medical Monitoring Project (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy571 · Cited by 17
Follow up of patients who have been recently sexually assaulted.
Parekh, V, & Beaumont Brown, C. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.4.349-a · Cited by 17
SEVERE OCULAR REACTIONS AFTER NEONATAL OCULAR PROPHYLAXIS WITH GENTAMICIN OPHTHALMIC OINTMENT
Nathawad, R., Mendez, H. A., Ahmad, A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f6c2e5 · Cited by 17
Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection
Manavi, K., Hettiarachchi, N., & Hodson, J. (2016) · International Journal of STD and AIDS · doi:10.1177/0956462415614723 · Cited by 17
Expedited Partner Therapy: Pharmacist Refusal of Legal Prescriptions
Borchardt, L. N., Pickett, M. L., Tan, K. T., Visotcky, A. M., & Drendel, A. L. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000751 · Cited by 16
Silva, M., Peixoto, A., Sarmento, J. A., Coelho, R., & Macedo, G. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4913/2017 · Cited by 16
Ongrádi, J., Stercz, B., Kövesdi, V., et al. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.1.8 · Cited by 16
You, C., Hamasuna, R., Ogawa, M., Fukuda, K., Hachisuga, T., Matsumoto, T., & Taniguchi, H. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.022 · Cited by 16
Analysis of Bioplex Syphilis IgG Quantitative Results in Different Patient Populations
Loeffelholz, M. J., Wen, T. S.-T., & Patel, J. A. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05335-11 · Cited by 16
Li, Z., Feng, Z., Liu, P., & Yan, C. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215623806 · Cited by 16
Suboptimal prenatal syphilis testing among commercially insured women in the United States, 2013.
Neblett Fanfair, R., Tao, G., Owusu-Edusei, K., Gift, T. L., & Bernstein, K. T. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000569 · Cited by 16
Thurman, A. R., Shain, R. N., Holden, A. E. C., Champion, J. D., Perdue, S. T., & Piper, J. M. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318151498f · Cited by 16
Anal use of the female condom: does uncertainty justify provider inaction?
Mantell, J. E., Kelvin, E. A., Exner, T. M., Hoffman, S., Needham, S., & Stein, Z. A. (2009) · AIDS Care · doi:10.1080/09540120902730005 · Cited by 16
Lesions of the neovagina—a review.
Heller, D. S. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000110 · Cited by 16
Loo, S. K. F., Tang, W., & Lo, K. K. (2009) · PubMed · Cited by 16
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002300 · Cited by 16
Prevalence and morbidity of urethralTrichomonas vaginalisin Japanese men with or without urethritis
Seike, K., Maeda, S., Kubota, Y., Tamaki, M., Yasuda, M., & Deguchi, T. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050702 · Cited by 16
‘Haemophilus quentini’ in the urethra of men complaining of urethritis symptoms
Horie, K., Ito, S., Hatazaki, K., Yasuda, M., Nakano, M., Kawakami, K., Fujita, Y., Ito, M., Ezaki, T., & Deguchi, T. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.08.007 · Cited by 16
The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2.
de Bruyn, G., Shiboski, S., van der Straten, A., Blanchard, K., Chipato, T., Ramjee, G., Montgomery, E., Padian, N., & for the MIRA team (2011) · Sexually Transmitted Infections · doi:10.1136/sti.2010.047142 · Cited by 16
Chambers, L. C., Morgan, J. L., Lowens, M. S., Robinson, T. S., Romano, S. S., Leipertz, G. L., Hughes, J. P., Golden, M. R., Khosropour, C. M., Fredricks, D. N., et al. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053634 · Cited by 16
Lazenby, G. B., Korte, J. E., Tillman, S., et al. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416680438 · Cited by 15
Boothby, M., Page, J., Pryor, R., et al. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.009374 · Cited by 15
Oral Lymphogranuloma Venereum and Cervical Lymphadenopathy: Case Report
Andrada, M. T., Dhar, J. K., & Wilde, H. (1974) · Military Medicine · doi:10.1093/milmed/139.2.99 · Cited by 15
Lesbians' Sexual History With Men: Implications for Taking a Sexual History
Diamant, A. L., Schuster, M. A., McGuigan, K., & Lever, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2730 · Cited by 15
Slutsker, J. S., Tsang, L.-Y. B., & Schillinger, J. A. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001163 · Cited by 15
Chavoustie, S. E., Gersten, J. K., Samuel, M. J., & Schwebke, J. R. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6500 · Cited by 15
Kim, H. J., Park, J. K., Park, S. C., et al. (2015) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-2015-000488 · Cited by 15
Repeat Episodes of Symptomatic Urethritis Due to a Uropathogenic Meningococcal Clade
Bazan, J. A., Tzeng, Y., Stephens, D. S., et al. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001079 · Cited by 15
Lymphogranuloma venereum presenting as an ulcer on the tongue
Riera‐Monroig, J., & Fuertes, I. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053787 · Cited by 15
Gowda, C., Kennedy, S., Glover, C., Prasad, M. R., Wang, L., & Honegger, J. R. (2018) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12481 · Cited by 15
Bubonic lymphogranuloma venereum with multidrug treatment failure
Vall-Mayans, M., Isaksson, J., Caballero, E., Sallés, B., & HERRMANN, B. F. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462413501158 · Cited by 15
(2015) · PubMed · Cited by 15
Roux, M., & Hoosen, A. A. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000540 · Cited by 15
Infantile Donovanosis Presenting as External Auditory Canal Polyps
Ramdial, P. K., Sing, Y., Ramburan, A., et al. (2012) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3182540ccb · Cited by 14
Ogbechie, O. A., Hacker, M. R., Dodge, L. E., et al. (2011) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050289 · Cited by 14
Allan-Blitz, L.-T., Konda, K. A., Calvo, G. M., Vargas, S. K., Leon, S. R., Segura, E. R., Caceres, C. F., & Klausner, J. D. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462417744098 · Cited by 14
Rivers, C. A., Muzny, C. A., & Schwebke, J. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02006-13 · Cited by 14
Self-citationPruritus der artefiziellen Vagina einer Transsexuellen durch Gonokokkeninfektion
Haustein, U.-F. (1995) · Der Hautarzt · doi:10.1007/s001050050354 · Cited by 14
Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database
Liu, H.-L., Chen, C., Pai, L., Hwu, Y., Lee, H.-M., & Chung, Y. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4327-7 · Cited by 14
Inadvertent use of Bicillin C-R to treat syphilis infection--Los Angeles, California, 1999-2004.
(2005) · PubMed · Cited by 14
Two concurrent enteric disease outbreaks among men who have sex with men, Minneapolis-St Paul area.
Danila, R. N., Eikmeier, D. L., Robinson, T. J., La Pointe, A., & DeVries, A. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu478 · Cited by 14
Turner, A. N., Feldblum, P. J., & Hoke, T. H. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181d70a03 · Cited by 14
Kawamura, N. (1978) · Sexually Transmitted Infections · doi:10.1136/sti.54.2.81 · Cited by 14
Kersh, E. N., Pillay, A., de Voux, A., & Chen, C. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000667 · Cited by 14
Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men
Kelley, C. F., Rosenberg, E. S., O'Hara, B. M., Sanchez, T., del Rio, C., & Sullivan, P. S. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318264248b · Cited by 14
Son, J., Miller, W. M., Tossone, K., Butcher, F., & Kuo, K. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.11.002 · Cited by 13
Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies.
(2014) · PubMed · Cited by 13
Ashraf, J., Radford, A. R., Turner, A., & Subramaniam, R. (2017) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2017.0064 · Cited by 13
Donovanosis in a child victim of sexual abuse: response to doxycycline treatment
Magalhães, B. M., Veasey, J. V., Mayor, S. A. S., et al. (2018) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20187948 · Cited by 13
The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth.
Mati, J. K. G., & Wallace, R. J. (1974) · PubMed · Cited by 13
Er det virkelig farlig å kombinere metronidazol og alkohol?
Fjeld, H., & Raknes, G. (2014) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.14.0081 · Cited by 13
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults
Romero, L., Huerfano, C., & Grillo‐Ardila, C. F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012492.pub2 · Cited by 12
Seth, P., Wang, G., Sizemore, E., & Hogben, M. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302778 · Cited by 12
Urine proves a poor specimen for culture of Trichomonas vaginalis in women
Mohamed, O. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.1.78 · Cited by 12
Are enteric infections sexually transmitted in British Columbia?
Narayan, S., & Galanis, E. (2016) · Canada Communicable Disease Report · doi:10.14745/ccdr.v42i02a01 · Cited by 12
Mohrmann, G., Noah, C., Sabranski, M., et al. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.4.19657 · Cited by 12
Sviben, M., Missoni, E. M., Meštrović, T., Vojnović, G., & Galinović, G. M. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051771 · Cited by 12
Hypertrophic Donavanosis in a Young Pregnant Woman
Liverani, C. A., Lattuada, D., Mangano, S., et al. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.10.002 · Cited by 12
Future treatment of gonorrhoea – novel emerging drugs are essential and in progress?
Unemo, M., & Shafer, W. M. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1039981 · Cited by 12
A literature review of herpes simplex virus hepatitis in pregnancy
Magawa, S., Tanaka, H., Furuhashi, F. H., et al. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1527311 · Cited by 11
Genital elephantiasis due to donovanosis: forgotten but not gone yet …
Narang, T. K., & Kanwar, A. J. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2012.012096 · Cited by 11
Two Cases of Neisseria meningitidis Proctitis in HIV-Positive Men Who Have Sex with Men
Gutierrez-Fernandez, J., Medina, V., Hidalgo-Tenorio, C., & Abad, R. (2017) · Emerging infectious diseases · doi:10.3201/eid2303.161039 · Cited by 11
Celum, C., Hong, T., Cent, A., Donnell, D. J., Morrow, R. A., Baeten, J. M., Firnhaber, C. S., Grinsztejn, B. G. J., Hosseinipour, M. C., Lalloo, U., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix029 · Cited by 11
Lucas, K. D., Miller, J. L., Eckert, V., Horne, R. L., Samuel, M. C., & Mohle‐Boetani, J. C. (2014) · Journal of Correctional Health Care · doi:10.1177/1078345814530869 · Cited by 11
Communication practices about HPV testing among providers in Federally Qualified Health Centers
Lin, L., Benard, V. B., Greek, A. A., Roland, K. B., Hawkins, N. A., & Saraiya, M. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.05.006 · Cited by 11
When should adenoviral non-gonococcal urethritis be suspected? Two case reports.
Avolio, M., Rosa, R. D., Modolo, M. L., Stano, P., & Camporese, A. (2014) · PubMed · Cited by 11
Immunogenicity of the hepatitis A vaccine 20 years after infant immunization.
Mosites, E., Seeman, S., Negus, S., Homan, C., Morris, J., Nelson, N. P., Spradling, P. R., Bruce, M., & McMahon, B. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.069 · Cited by 11
Managing Minimally Abnormal Cervical Cancer Screening Test Results
Sawaya, G. F., Lamar, R., & Perkins, R. B. (2020) · JAMA · doi:10.1001/jama.2020.12488 · Cited by 10
Necrotizing Urethritis due toAerococcus urinae
Babaeer, A. A., Nader, C. M., Iacoviello, V., et al. (2015) · Case Reports in Urology · doi:10.1155/2015/136147 · Cited by 10
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
